Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment

NCT04045691 · clinicaltrials.gov ↗

RECRUITING

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma Stage IV
Melanoma Stage III

Interventions

DRUG: Encorafenib
DRUG: Binimetinib

Sponsor

Pierre Fabre Pharma GmbH

Collaborators

[object Object]
[object Object]